Anavex Life Sciences Corp. (FRA:12X1)

Anavex Life Sciences Statistics

Total Valuation

FRA:12X1 has a market cap or net worth of EUR 295.12 million. The enterprise value is 206.65 million.

Market Cap	295.12M
Enterprise Value	206.65M

Important Dates

The last earnings date was Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	89.35M
Shares Outstanding	n/a
Shares Change (YoY)	+2.18%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	3.23%
Owned by Institutions (%)	36.66%
Float	86.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.65
P/TBV Ratio	3.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.23
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.60

Current Ratio	11.60
Quick Ratio	11.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.11% and return on invested capital (ROIC) is -29.49%.

Return on Equity (ROE)	-43.11%
Return on Assets (ROA)	-26.51%
Return on Invested Capital (ROIC)	-29.49%
Return on Capital Employed (ROCE)	-53.51%
Revenue Per Employee	n/a
Profits Per Employee	-1.16M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.53%
50-Day Moving Average	6.32
200-Day Moving Average	7.64
Relative Strength Index (RSI)	29.80
Average Volume (20 Days)	1,104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	13.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.26M
Pretax Income	-39.53M
Net Income	-39.53M
EBITDA	n/a
EBIT	-43.26M
Earnings Per Share (EPS)	-0.46

Balance Sheet

The company has 87.43 million in cash and n/a in debt, giving a net cash position of 87.43 million.

Cash & Cash Equivalents	87.43M
Total Debt	n/a
Net Cash	87.43M
Net Cash Per Share	n/a
Equity (Book Value)	80.86M
Book Value Per Share	0.93
Working Capital	80.86M

Cash Flow

Operating Cash Flow	-33.28M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:12X1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.18%
Shareholder Yield	-2.18%
Earnings Yield	-13.39%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2